Author:
Martin Natasha K.,Vickerman Peter,Hickman Matthew
Funder
National Institute for Drug Abuse
University of California San Diego Center for AIDS Research
National Institute of Health
NIHR Health Protection Research Unit in Evaluation of Interventions
Reference20 articles.
1. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention;Martin;Curr Opin HIV AIDS,2015
2. Boerekamps A, van den Berk G, Lauw F, et al. SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCH HIV+MSM AFTER DAA ROLL OUT. Abstract 137LB. CROI 2017; February 13–16, 2017, 2017; Seattle, Washington.
3. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward);Dore;J Viral Hepatitis,2014
4. Cost-effectiveness of increasing HCV case-finding for people who inject drugs in specialist addiction services and prisons;Martin;BMJ,2013
5. Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis;Martin;Hepatology,2016
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献